OTCMKTS:GTHP

Guided Therapeutics Stock Forecast, Price & News

$0.59

-0.04 (-6.35 %)

(As of 07/30/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.53

▼

$0.64

50-Day Range

$0.48

▼

$0.71

52-Week Range

$0.16

▼

$1.00

Volume6,131 shs

Average Volume15,571 shs

Market Capitalization$7.85 million

P/E RatioN/A

Dividend YieldN/A

Beta0.83

30 days | 90 days | 365 days | Advanced Chart

Receive GTHP News and Ratings via Email

Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

About Guided Therapeutics

Guided Therapeutics, Inc. engages in the development of medical devices. It focuses on the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The company was founded by Shabbir Bakir Bambot and Richard L. Fowler on October 27, 1992 and is headquartered in Norcross, GA.

Short Interest in Guided Therapeutics, Inc. (OTCMKTS:GTHP) Rises By 240.0%
July 14, 2021 | americanbankingnews.com

Company Profile for Guided Therapeutics, Inc.
October 26, 2020 | businesswire.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:GTHP
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.guidedinc.com
Phone(770) 242-8723
Employees6
Year FoundedN/A

Sales & Book Value

Annual Sales$100,000.00
Price / Sales78.47
Cash Flow$0.02 per share
Price / Cash Flow38.27
Book Value($1.03) per share
Price / Book-0.57

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares13,300,000
Market Cap$7.85 million
Next Earnings Date8/18/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.33 out of 5 stars

Medical Sector

1923rd out of 2,223 stocks

Electromedical Equipment Industry

56th out of 65 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Guided Therapeutics.

0.0 Community Rank

Outperform Votes
Guided Therapeutics has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Guided Therapeutics has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Guided Therapeutics and other stocks. Vote “Outperform” if you believe GTHP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GTHP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Guided Therapeutics does not currently pay a dividend.
Dividend Growth
Guided Therapeutics does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Guided Therapeutics insiders have not sold or bought any company stock.
Percentage Held by Insiders
66.83% of the stock of Guided Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Guided Therapeutics is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Guided Therapeutics is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Guided Therapeutics (OTCMKTS:GTHP) Frequently Asked Questions

What stocks does MarketBeat like better than Guided Therapeutics?

Wall Street analysts have given Guided Therapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Guided Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Guided Therapeutics?

Guided Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 2,300 shares, an increase of 35.3% from the June 30th total of 1,700 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is currently 0.3 days.
View Guided Therapeutics' Short Interest.

When is Guided Therapeutics' next earnings date?

Guided Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, August 18th 2021.
View our earnings forecast for Guided Therapeutics.

Who are Guided Therapeutics' key executives?

Guided Therapeutics' management team includes the following people:

Gene S. Cartwright, President, Chief Executive Officer, CFO & Director
Mark L. Faupel, Secretary, COO & Director
Richard L. Fowler, Senior Vice President-Engineering
Bill Wells, Communications Director

Who are some of Guided Therapeutics' key competitors?

Some companies that are related to Guided Therapeutics include Viveve Medical (VIVE), Nuwellis (NUWE), Precision Optics (PEYE), Star Equity (STRR), Positron (POSC), Vaso (VASO), Micron Solutions (MICR), ADM Tronics Unlimited (ADMT), ReShape Lifesciences (RSLSD), Nexeon MedSystems (NXNN), Magna-Lab (MAGAA), Aksys (AKSY), Aradigm (ARDMQ), Echo Therapeutics (ECTE) and Escalon Medical (ESMC).
View all of GTHP's competitors.

What is Guided Therapeutics' stock symbol?

Guided Therapeutics trades on the OTCMKTS under the ticker symbol "GTHP."

How do I buy shares of Guided Therapeutics?

Shares of GTHP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Guided Therapeutics' stock price today?

One share of GTHP stock can currently be purchased for approximately $0.59.

How much money does Guided Therapeutics make?

Guided Therapeutics has a market capitalization of $7.85 million and generates $100,000.00 in revenue each year.

How many employees does Guided Therapeutics have?

Guided Therapeutics employs 6 workers across the globe.

What is Guided Therapeutics' official website?

The official website for Guided Therapeutics is www.guidedinc.com.

Where are Guided Therapeutics' headquarters?

Guided Therapeutics is headquartered at 5835 PEACHTREE CORNERS EAST SUITE D, PEACHTREE CORNERS GA, 30092.

How can I contact Guided Therapeutics?

Guided Therapeutics' mailing address is 5835 PEACHTREE CORNERS EAST SUITE D, PEACHTREE CORNERS GA, 30092. The company can be reached via phone at (770) 242-8723 or via email at [email protected]

This page was last updated on 7/31/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Guided Therapeutics Stock Forecast, Price & News

About Guided Therapeutics

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

0.0 Dividend Strength

Dividend Yield

Dividend Growth